Skip to main content
Clinical Trials/NCT04807322
NCT04807322
Completed
Not Applicable

Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

Bürgerspital Solothurn1 site in 1 country110 target enrollmentMarch 24, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Reverse Total Shoulder Arthroplasty
Sponsor
Bürgerspital Solothurn
Enrollment
110
Locations
1
Primary Endpoint
Quality adjusted life year (QALY)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.

Detailed Description

This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).

Registry
clinicaltrials.gov
Start Date
March 24, 2019
End Date
December 21, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mai Lan Dao Trong

Attending physician shoulder and elbow surgery

Bürgerspital Solothurn

Eligibility Criteria

Inclusion Criteria

  • Patients older than 83 years at time of surgery
  • Patients who received a reverse total shoulder arthroplasty

Exclusion Criteria

  • Patients younger than 83 years at time of surgery

Outcomes

Primary Outcomes

Quality adjusted life year (QALY)

Time Frame: until august 2020

The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.

Patient reported outcome score: ASES

Time Frame: until august 2020

American Shoulder and Elbow Society (ASES) Score

Mortality

Time Frame: until august 2020

Survivership

Patient reported outcome score: VAS

Time Frame: until august 2020

Visual analog score (VAS)

Patient reported outcome score: QuickDASH

Time Frame: until august 2020

Quick Disabilities of the arm, shoulder and hand (DASH) Score,

Complication rate

Time Frame: until august 2020

postoperative complications requiring surgical intervention

Secondary Outcomes

  • Patient demographics(at time of surgery)

Study Sites (1)

Loading locations...

Similar Trials